ContractJanuary 26th, 2022
FiledJanuary 26th, 2022CLINICAL TRIAL AGREEMENT PROTOCOL # XXXXXX SMLOUVA O KLINICKÉM HODNOCENÍ PROTOKOL # XXXXXX This clinical study agreement on conducting a clinical study made in compliance with the provi- sion of § 1746, paragraph 2, Act No. 89/2012 Coll., Civil Code, as amended and in compliance with Act No. 378/2007 Coll. on Pharmaceuticals, as amended (the “Agreement”) is entered into as of the date of last signature hereto (the “Effective Date”) by and between Idorsia Pharmaceuticals Ltd, having as a place of business Hegenheimer- mattweg 91 CH – 4123 Allschwil, Switzerland (“Idorsia”), Nemocnice Pardubického kraje, a.s. located at Kyjevska 44, 532 03 Pardubice repre- sented by Tomáš Gottvald, M.D., MHA, chairman of the Board and Vladimír Ninger, M.D., Ph.D, member of the Board; ID: 27520536; VAT: CZ CZ27520536; Bank connection: ČSOB, Pardu- bice branch office, Bank account: 280123725/0300; registered in the Commercial Register kept by the Regional Court in Hradec Kralove, Section B, Insertion 2629